Literature DB >> 21619719

Study on the sampling of methadone from exhaled breath.

Olof Beck1, Sören Sandqvist, Michael Böttcher, Paul Eriksen, Johan Franck, Göran Palmskog.   

Abstract

This study aimed at develop and validate the procedure for collecting exhaled breath for drug testing. Patients receiving methadone maintenance treatment were recruited for the study. Methadone levels were measured using liquid chromatography- electrospray-tandem mass spectrometry. The sampling device was based on a 47-mm C(18) filter and used under pressure to aid flow through the filter. The mouth was rinsed before sampling, and the device was constructed to protect against any saliva contamination. Methadone was present in breath samples before and after the daily intake of methadone. The mean (± SD) pre-dose level was found to be 135 ± 109 pg/min (n = 48, median 121). The exhaled methadone increased after dose intake. Saliva levels of methadone were high in comparison with exhaled breath levels. Saliva contamination was suspected in about 10% of the collected samples. Similar results were obtained using 1, 3, and 10 min sampling times. The inter- and intraindividual variability were found to be similar and in the order of 50%. Alternative sampling using XAD-2 beads and solid-phase microextraction fiber was found to be possible and enables sampling with low back pressure and with no need for pump assistance. The presented results confirm that breath testing is a new possibility for the detection of drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619719     DOI: 10.1093/anatox/35.5.257

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  4 in total

1.  A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.

Authors:  Maryam Khoubnasabjafari; Elaheh Rahimpour; Morteza Samini; Vahid Jouyban-Gharamaleki; Lan Chen; Donghao Chen; Hak-Kim Chan; Abolghasem Jouyban
Journal:  Daru       Date:  2019-03-07       Impact factor: 3.117

2.  Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Authors:  Sarah K Himes; Karl B Scheidweiler; Olof Beck; David A Gorelick; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-17       Impact factor: 8.327

3.  Methadone Concentrations in Exhaled Breath Condensate, Serum and Urine of Patients Under Maintenance Treatment.

Authors:  Maryam Khoubnasabjafari; Khalil Ansarin; Vahid Jouyban-Gharamaleki; Vahid Panahi-Azar; Samin Hamidi; Zhila Azarmir; Abolghasem Jouyban
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

4.  Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis.

Authors:  Matthijs D Kruizinga; Willem A J Birkhoff; Michiel J van Esdonk; Naomi B Klarenbeek; Tomasz Cholewinski; Tessa Nelemans; Melloney J Dröge; Adam F Cohen; Rob G J A Zuiker
Journal:  Br J Clin Pharmacol       Date:  2020-01-03       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.